- Legend Biotech USA, Inc. (Omaha, NE)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Aequor (Thousand Oaks, CA)
- …(GCR-PEX) team. This senior role balances advanced laboratory execution ( cell culture, reagent generation and characterization) with technical leadership of ... values.Responsibilities include: Create and characterize adherent and suspension assay cell lines and develop high-quality assay-ready (ready-to-plate) cell … more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Philadelphia, PA)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
Related Job Searches:
Account Director Cell Gene,
Associate Director Cell Therapy,
Car Cell Therapy Experience,
Cell Site Analyst,
Director Business Development Cell,
Executive Director Cell Therapy,
Senior Cell Therapy Account,
Senior Manager Cell Therapy,
Stem Cell Lab,
Stem Cell Scientist